Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02800486
Title Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Northwell Health
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Lenox Hill Brain Tumor Center RECRUITING New York New York 10075 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field